NFKB1 and early-onset autosomal dominant Alzheimer disease: In neuroinflammation, quantum dots can inhibit inflammatory signaling pathways such as NLRP3 inflammatory vesicles, NF-κB, and Caspase-1; reduce the release of inflammatory factors [112]; and reduce the toxic aggregation of Aβ to decrease Alzheimer’s disease-related neuroinflammation [113].